Filing Details

Accession Number:
0001140361-17-005058
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-08 12:52:37
Reporting Period:
2017-02-06
Filing Date:
2017-02-08
Accepted Time:
2017-02-08 12:52:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1444380 Nevro Corp NVRO Surgical & Medical Instruments & Apparatus (3841) 562568057
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1622421 Michael Enxing C/O Nevro Corp.
1800 Bridge Parkway
Redwood City CA 94065
Vp Of Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-06 1,500 $3.60 78,963 No 4 M Direct
Common Stock Disposition 2017-02-06 1,500 $93.27 77,463 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-02-06 1,500 $0.00 1,500 $3.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,108 2022-12-17 No 4 M Direct
Footnotes
  1. Includes 2,500 restricted stock units.
  2. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $92.86 to $93.64, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. 100% of the shares subject to the option are fully vested and exercisable.